Literature DB >> 8839681

Controlled release dosage forms: from ground to space.

P Colombo1, R Bettini, M T Peracchia, P Santi.   

Abstract

Controlled release of drugs is one of the most significant advances in pharmacy. Due to the proposition of new routes for drug administration, today it is considered as a part of 'drug delivery'. Developments in biotechnology producing natural molecules, peptides and proteins have allowed high activity substances that require careful formulation for administration. Drug delivery is the discipline striving to sole the problem of optimisation of drug efficacy. In this contribution the last 25 years of drug delivery research have been examined pointing out the most significant break-through steps.

Mesh:

Substances:

Year:  1996        PMID: 8839681     DOI: 10.1007/BF03190256

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  5 in total

1.  Sustained release of hCG minipellet for newt experiment in space.

Authors:  M Imamizo; M Yoshida; K Fujioka; Y Takada; A Hisada; A Izumi-Kurotani; M Yamashita
Journal:  Biol Sci Space       Date:  1994-12

2.  Translating safety, efficacy and compliance into economic value for controlled release dosage forms.

Authors:  M P Cramer; S R Saks
Journal:  Pharmacoeconomics       Date:  1994-06       Impact factor: 4.981

3.  Ultrasound-mediated transdermal protein delivery.

Authors:  S Mitragotri; D Blankschtein; R Langer
Journal:  Science       Date:  1995-08-11       Impact factor: 47.728

4.  In vitro and in vivo evaluation of mucoadhesive microspheres prepared for the gastrointestinal tract using polyglycerol esters of fatty acids and a poly(acrylic acid) derivative.

Authors:  Y Akiyama; N Nagahara; T Kashihara; S Hirai; H Toguchi
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

5.  A new application for liposomes in cancer therapy. Immunoliposomes bearing enzymes (immuno-enzymosomes) for site-specific activation of prodrugs.

Authors:  M H Vingerhoeds; H J Haisma; M van Muijen; R B van de Rijt; D J Crommelin; G Storm
Journal:  FEBS Lett       Date:  1993-12-28       Impact factor: 4.124

  5 in total
  1 in total

Review 1.  Current status of sustained release formulations in the treatment of hypertension. An overview.

Authors:  E Mutschler; H Knauf
Journal:  Clin Pharmacokinet       Date:  1999       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.